Hypertensive disorders of pregnancy (HDP) remain a major concern for both maternal and fetal health globally. Beyond the immediate delivery complications, these conditions often serve as a physiological stress test for the cardiovascular system. Recent research has focused on the long-term hypertensive disorders of pregnancy cardiovascular risk to determine how clinical management decisions during pregnancy might influence heart health years later.

Study Overview: Latency and Heart Health

A recent secondary analysis of the nuMoM2b-Heart Health Study investigated the association between the latency of expectant management and future cardiovascular health markers. Researchers examined 142 participants who experienced preterm-onset HDP during their first pregnancy. The study specifically looked at cardiovascular measures taken 2 to 7 years after delivery, focusing on individuals without pre-existing diabetes or hypertension.

The primary outcome measured was the American Heart Association’s Life’s Essential 8 health factor score. This composite score includes body mass index (BMI), blood pressure, hemoglobin A1C, and non-high-density lipoprotein (non-HDL) cholesterol. Additionally, investigators assessed secondary markers such as C-reactive protein (CRP) and N-terminal probrain natriuretic peptide (NT-proBNP) to identify subclinical inflammation and cardiac strain.

Impact on Hypertensive Disorders of Pregnancy Cardiovascular Risk

The results revealed that longer latency—the time between diagnosis and delivery—was not linked to a significant difference in the overall Life’s Essential 8 score. However, specific components showed concerning trends. Participants with longer latency had significantly lower non-HDL cholesterol scores and higher high-sensitivity CRP levels. These findings suggest that while clinical cardiovascular disease may not yet be manifest, subclinical inflammatory and lipid changes are present.

Furthermore, sensitivity analyses indicated that early-onset and severe HDP subtypes did not account for these latency-related differences. Therefore, the duration of exposure to the hypertensive state itself may contribute to a heightened subclinical risk profile. This underscores the importance of long-term monitoring for women who undergo expectant management for preterm HDP.

Clinical Implications for Practice

For clinicians in India and globally, these findings emphasize that the postpartum period is a critical window for intervention. Although expectant management is vital for neonatal maturity, it may leave a lasting subclinical imprint on maternal health. Consequently, clinicians should prioritize aggressive lipid management and lifestyle modifications in the years following a complicated pregnancy. Regular screening for inflammatory markers and lipid profiles could help in early risk stratification.

Frequently Asked Questions

What is meant by 'latency' in HDP management?

Latency refers to the interval between the initial diagnosis of a hypertensive disorder of pregnancy and the actual time of delivery. In expectant management, clinicians try to prolong this period to allow for further fetal development.

Does a longer latency increase the risk of clinical heart disease?

The study found that while overall health scores were similar, longer latency was associated with higher inflammation and worse lipid levels. These are subclinical markers that may eventually lead to higher hypertensive disorders of pregnancy cardiovascular risk later in life.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Shree S et al. Latency of Hypertensive Disorders of Pregnancy and Cardiovascular Risk 2-7 Years After Delivery. Obstet Gynecol. 2026 Apr 09. doi: 10.1097/AOG.0000000000006293. PMID: 41955621.

Haas DM et al. Pregnancy as a Window to Future Cardiovascular Health: Design and Implementation of the nuMoM2b Heart Health Study. Am J Obstet Gynecol. 2016;215(4):511.e1-511.e14.

Garovic VD et al. Incidence and Long-Term Outcomes of Hypertensive Disorders of Pregnancy. J Am Coll Cardiol. 2020;75(18):2323-2334.